Skeletal-Related Events in Patients With Multiple Myeloma and Prostate Cancer Who Receive Standard vs Extended-Interval Bisphosphonate Dosing.

In patients with multiple myeloma and prostate cancer, extending the bisphosphonate dosing interval may help decrease medication-related morbidity without compromising therapeutic benefit.

Evaluation of a method to improve the consent process: improved data retention with stagnant comprehension.

Our study explored whether a simple, cost-effective intervention directed only at physicians could improve patient comprehension with informed consent process. In our medical university oncology clinic, we performed a baseline survey on 69 patients receiving new therapy, testing for comprehension of the important components of the informed consent process. We then instituted a three-part intervention, including (1) physician education, (2) an available toxicity list, and (3) a checklist to ensure physician compliance.